RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Novavax, Inc. (“Novavax”) (NASDAQ: NVAX). The action charges Novavax with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Novavax’s materially misleading statements, Novavax investors have suffered significant losses.
“faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards”
Tweet this
CANNOT VIEW THIS VIDEO? PLEASE CLICK HERE
CLICK HERE TO SUBMIT YOUR NOVAVAX LOSSES
LEAD PLAINTIFF DEADLINE: January 11, 2022
CLASS PERIOD: March 2, 2021 through October 19, 2021
CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
James Maro, Esq. (484) 270-1453 or Toll Free (844) 887-9500 or Email at [email protected]
NOVAVAX’S ALLEGED MISCONDUCT
Novavax is a biotechnology company that develops vaccines for serious infectious diseases, including NVX-CoV2373, a vaccine developed for COVID-19. Prior to March, 2021, Novavax announced its plan to complete Emergency Use Authorization (“EUA”) submissions for NVX-CoV2373 with the U.S. Food and Drug Administration (“FDA”) in the second quarter of 2021.
On March 2, 2021, Novavax issued a press release stating the company had potential for EUA filing in the second quarter of 2021, and that distribution plans for NVX-CoV2373,...
[OSEN=Seon Mi-kyung Reporter] Rapper Yang Hong-won, who has sparked controversy over infidelity allegations just five days after his marriage, is drawing attention for reportedly singing his wife W...